Budget vs premium
Gala vs Maximus: Which Costs Less Over 12 Months? (2026)
Gala or Maximus? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.7 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
If Gala and Maximus are the two tabs still open, the deciding information is not on either homepage — it is in what happens after the first month.
On the number that matters after the first month, they are not close: Maximus runs $133/mo against $249/mo at Gala — 87% more, every month, for the same drug class.
The comparison below starts from published pricing, converts it into annual cost, and then asks what the more expensive side is delivering for the difference. Where a provider quotes only after intake, that is recorded as the answer rather than replaced with a guess.
The short answer
- Lowest 12-month cost
- Maximus — $1,596 against $2,148 at Gala, on each provider's own best published pricing.
- Most predictable bill
- Maximus — Flat rate at every dose, so titration does not change what you are charged.
- Quickest to start
- Gala — Fully online, no in-office visits, then home delivery.
- Easiest to pay for
- Gala — Neither publishes financing; both expect the full amount monthly.
The short version: Gala vs Maximus
The rows below are the ones that differ enough between these two to be worth your attention.
| Gala | Maximus | |
|---|---|---|
| Advertised price | From $249/mo, as low as $179/mo on longer plans | $132.99/mo |
| Rate after promotions | $249/mo | $133/mo |
| Pricing structure | Cheaper per month the longer you commit | Flat rate at every dose |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide |
| Payment options | Card only, no financing published | Card only, no financing published |
| Membership fee | None | None |
| How fast you start | Fully online, no in-office visits | Telemedicine intake, no clinic visits |
| State coverage | Not published | Not published |
| Patient reviews | 2,870 | 2,896 |
| eRxDoctor score | 7.7/10 | 7.0/10 |
The real cost: six months and twelve
Comparing entry prices across these two would be actively misleading, because they escalate differently. What matters is the total at the point most people are still in treatment, so both programs are extended to six and twelve months below.
| Gala | Maximus | |
|---|---|---|
| First month | $249 | $133 |
| Months 2 onward | $249/mo | $133/mo |
| 6-month total | $1,494 | $798 |
| 12-month total | $2,988 | $1,596 |
| Best published plan | longer-term plan at $179/mo — $2,148/yr | No multi-month discount published |
Over a year that is a $552 difference, in Maximus's favor. Whether it is the right call depends on whether Gala gives you $46 a month of something you will use.
Is Gala worth the premium?
The gap runs to 87% a month. What Gala offers for it: provider check-ins and dose monitoring included, plus home delivery.
Maximus's answer is a low flat rate with a simple direct-pay structure and nothing bolted on. What it does not carry: the smallest patient base here, with limited published detail on tirzepatide.
For a patient who has taken a GLP-1 before, knows how they titrate and needs a reliable monthly refill, the cheaper program is usually the correct one and the premium is a donation. For a first prescription, the calculus changes.
Gala: what you are buying
Gala GLP-1 is a direct-pay telehealth platform offering compounded semaglutide and tirzepatide with provider check-ins and home delivery. What it is really selling here is a direct-pay model with dose monitoring included rather than sold as an add-on.
You start with fully online, no in-office visits; medication arrives via home delivery. The price behaves as cheaper per month the longer you commit.
Provider check-ins and dose monitoring included. The formulary covers compounded semaglutide and compounded tirzepatide.
Gala pros
- Direct-pay model, no insurance or prior authorizations needed
- Provider check-ins and dose monitoring included
- Fully online, no in-office visits required
Gala cons
- Lower long-term pricing requires a multi-month commitment
- Higher entry price than several compounded competitors
Against Maximus specifically, the trade you are making: the entry price sits above most compounded competitors unless you commit to a longer term.
A closer look at Maximus
$132.99 per Month In this pairing, its distinguishing feature is a low flat rate with a simple direct-pay structure and nothing bolted on.
The process is telemedicine intake, no clinic visits, then home delivery. On money, expect flat rate at every dose — published upfront.
What continues after the first shipment: prescriptions approved by licensed doctors, filled through U.S. pharmacies. Formulary: compounded semaglutide.
Maximus pros
- Convenient telemedicine access with no clinic visits
- Low flat rate at $132.99/month
- Medication filled through trusted U.S. pharmacies
- Prescriptions approved by licensed doctors
Maximus cons
- Smallest patient base on this list, limited public reviews and track record
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Limited published detail on tirzepatide availability and program features
The cost of choosing this over Gala: the smallest patient base here, with limited published detail on tirzepatide.
Who each program is actually built for
Choose Gala if:
- you want to start on their timeline: fully online, no in-office visits
- the level of clinical contact suits you: provider check-ins and dose monitoring included
- the feature you would actually use: a direct-pay model with dose monitoring included rather than sold as an add-on
- you are willing to commit for a term in exchange for a lower effective rate (longer-term plan at $179/mo)
Choose Maximus if:
- the monthly rate is the constraint — $133/mo against $249/mo
- you want the price you sign up at to survive titration
- the twelve-month total is what you are optimizing ($1,596 against $2,988)
- the feature you would actually use: a low flat rate with a simple direct-pay structure and nothing bolted on
The trade-offs, stated plainly
On price. The monthly gap is 87% in Maximus's favor. Whether that is a saving or a false economy turns on one thing: the smallest patient base here, with limited published detail on tirzepatide.
On commitment. Gala rewards a longer commitment (longer-term plan at $179/mo), which lowers the effective rate but ties up money before you know how you respond to the medication. Neither publishes financing options, so plan for the full amount each month.
On clinical contact. The support models differ — provider check-ins and dose monitoring included against prescriptions approved by licensed doctors, filled through U.S. pharmacies — and that difference is felt in week two, not week one.
On medication. Gala covers compounded semaglutide and compounded tirzepatide; Maximus covers compounded semaglutide. Neither locks you out of a molecule the other offers, so this is unlikely to be the deciding factor.
The medication, not the platform
Before either program's marketing claims, the underlying evidence — which belongs to the medication, not the platform.
The FDA publishes an ongoing record of semaglutide products marketed for diabetes and weight loss, and which of them it has actually approved, per FDA.
Dosing errors are the failure mode the FDA has flagged most often with unapproved GLP-1 products, particularly where a patient draws the dose themselves, per FDA.
Neither platform's marketing changes any of that. It is the same evidence base whichever one takes your card.
Gala vs Maximus: common questions
Which is cheaper to start, Gala or Maximus?
Maximus, at $133 against $249. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
How fast can I start with Gala compared with Maximus?
Gala advertises fully online, no in-office visits, with home delivery. Maximus advertises telemedicine intake, no clinic visits, with home delivery. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Do Gala or Maximus take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
Are Gala and Maximus legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. Gala operates on cheaper per month the longer you commit with pricing published upfront, Maximus on flat rate at every dose, published upfront. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
Is Gala or Maximus better for a first GLP-1 prescription?
For a first prescription, weight support over price. Gala offers more contact (provider check-ins and dose monitoring included), which matters most in the first eight weeks when side effects and titration questions are at their peak. Once you know how you tolerate the medication, the cheaper program becomes the rational choice.
What happens if I stop taking the medication?
Both programs are month to month, which makes stopping easy and makes the consequence of stopping the thing to plan for: published extension data shows most of the lost weight returns within about a year. That is an argument for choosing on annual cost rather than entry price.
The verdict
Maximus is the cheaper year by $552, and for a straightforward course of treatment that settles it.
The case for Gala is a direct-pay model with dose monitoring included rather than sold as an add-on. That is worth $46 a month to some patients and nothing at all to others — be honest about which you are.
Neither choice is irreversible. Start with the program whose weaknesses you can tolerate, and reassess at month three when you know how you respond to the medication.
Keep comparing
- MedVi vs GalaHead to head
- Yucca Health vs GalaBudget vs premium
- Enhance MD vs MaximusBudget vs premium
- Directmeds vs MaximusPublished price vs quote-only
- TrimRx vs JoinFridaysBudget vs premium
- TrimRx vs MedViBudget vs premium
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Gala or Maximus, and does not sell treatment. Read our ranking methodology.